NCT02600533

Brief Summary

This study will measure the effects of an office-based, clinical trial education video on clinical trial knowledge and enrollment in clinical trials, in a clinical sample with no previous history of clinical trial participation. This study will also determine the feasibility of implementing an office-based video educational program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 9, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2017

Completed
Last Updated

September 11, 2017

Status Verified

September 1, 2017

Enrollment Period

2.6 years

First QC Date

November 5, 2015

Last Update Submit

September 7, 2017

Conditions

Keywords

minority group recruitmentstages of implementationclinical trials education

Outcome Measures

Primary Outcomes (1)

  • study feasibility

    The stages of implementation completion (SIC) measure will be used as an internal tool utilized by the study team to track time to achievement of key implementation milestones. An 8-stage implementation plan to measure feasibility of the office-based educational program will be executed across 3 phases. Three scores will be derived from the SIC measure. The first score is the number of stages completed. The second score is the time spent at each stage. The third score is the proportion of activities completed at each stage. Implementation of the SIC model poses no additional burden on study participants.

    12 months

Secondary Outcomes (3)

  • Clinical trial participation

    12 months

  • Clinical trial knowledge survey

    7-10 days

  • Likelihood to participate survey

    7-10 days

Study Arms (2)

Standard care/control group

NO INTERVENTION

First, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the standard of care group will be provided standard educational resources (booklet and DVD), with no additional instructions. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.

Video viewing group

EXPERIMENTAL

First, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the video viewing group will watch the 10-minute DVD video on tablet devices using headphones in the clinic. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.

Procedure: Video viewing group

Interventions

First, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the video viewing group will watch the 10-minute DVD video on tablet devices using headphones in the clinic. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.

Also known as: video group
Video viewing group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be patients of Vanderbilt-Ingram Cancer Center (VICC) with a diagnosis of cancer Participants will have no previous history of clinical trial research participation

You may not qualify if:

  • Previous history of clinical trial research participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Study Officials

  • Consuelo H. Wilkins, MD

    Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Director of the Meharry-Vanderbilt Alliance, Associate Professor

Study Record Dates

First Submitted

November 5, 2015

First Posted

November 9, 2015

Study Start

December 1, 2014

Primary Completion

June 28, 2017

Study Completion

June 28, 2017

Last Updated

September 11, 2017

Record last verified: 2017-09

Locations